OPTIMIZATION OF TREATMENT OF ATYPICAL PNEUMONIA DUE TO HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN NEWBORNS

Main Article Content

Ibragimova Marina Fedorovna
Esanova Munira Ravshanovna

Abstract

Acute respiratory pathology occupies a leading place in the structure of morbidity in children. The leading place among them belongs to pneumonia, which is characterized by a high prevalence in the early age group, severity of the course, and the possibility of transition to severe forms. The purpose of the study is to develop new systems for complex therapy and rehabilitation of newborns with atypical pneumonia against the background of hypoxic-ischemic encephalopathy. Materials and methods of research: Group I – 40 children who received traditional treatment, of which 28 had a moderate-severe form and 12 had a severe form. Group II – 45 children who received, in addition to traditional treatment, cytochrome C, immunomodulin and of these, 32 are moderately severe and 13 are severe.

Article Details

How to Cite
Ibragimova Marina Fedorovna, & Esanova Munira Ravshanovna. (2024). OPTIMIZATION OF TREATMENT OF ATYPICAL PNEUMONIA DUE TO HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN NEWBORNS. Research Focus International Scientific Journal, 3(1), 220–223. Retrieved from https://refocus.uz/index.php/1/article/view/767
Section
14.00.00 – Medical sciences

References

Pravdukhina, G.P. Morphofunctional basis of the formation of encephalopathy in perinatal hypoxic-ischemic damage to the central nervous system / G.P. Pravdukhina, V.V. Semchenko // Med. science and education Ural. - 2012. -T. 13, No. 4. -S. 68-72.

Sergeeva V.A., Aleksandrovich Yu.S., Petrenkova N.S. Predictors

hypoxic-ischemic encephalopathy in newborns children. Bulletin of anesthesiology and resuscitation. 2017;14(4):16-22.

Fedorovna, I. M. (2022). The influence of risk factors on the development of atypical pneumonia in young children. Asian journal of pharmaceutical and biological research, 11(2).

Ибрагимова, М. Ф. (2022). Применение препарата пектолван ц при лечении атипичной пневмонии у детей. Биология, 3, 136.

Ибрагимова, М. Ф., & Атаева, М. С. (2022). BOLALARDA ATIPIK PNEVMONIYANI DIAGNOSTIKA VA DAVOLASH USULLARINI TAKOMILLASHTIRISH. Журнал кардиореспираторных исследований, 3(2).

Shavazi Н., & Ibragimova М. (2023). USE OF POLYOXIDONIUM IN THE TREATMENT OF OBSTRUCTIVE BRONCHITIS IN CHILDREN. International Journal of Scientific Pediatrics, (1), 26–28. https://doi.org/10.56121/2181-2926-2023-1-26-28.

Fedorovna, I. M., & Mamedovich, S. N. (2022). Improving Treatment in Children with Community-Acquired Pneumonia with Atypical Etiology. Telematique, 4644-4648.

Ibragimova, M. F. (2022). DIAGNOSTIC CRITERIA FOR PNEUMONIA OF ATYPICAL ETIOLOGY IN CHILDREN. British medical journal, 2(5).

Fedorovna, I. M., & Shodiyorovna, G. D. (2023). IMPROVED DIAGNOSIS AND TREATMENT OF ATYPICAL PNEUMONIA IN CHILDREN. Thematics Journal of Applied Sciences, 7(1).

Shavazi, N., Ibragimova, M., & Munira, E. (2023). СОСТОЯНИЕ КЛЕТОЧНОГО ИММУНИТЕТА У БОЛЬНЫХ С ОБСТРУКТИВНЫМ БРОНХИТОМ. International Journal of Scientific Pediatrics, 2(9), 330-332.

Shavazi, N. M., Tursunkulova, D. A., Turaeva, N. O., & Ibragimova, M. F. (2023). INFLUENCE OF NEGATIVE PREMORBID AND ECOLOPATHOLOGICAL FACTORS ON THE COURSE OF OBSTRUCTIVE BRONCHITIS IN CHILDREN AGAINST THE BACKGROUND OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY. British Medical Journal, 3(2).